BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 25882948)

  • 1. [A clinical prediction model for N2 lymph node metastasis in clinical stage I non-small cell lung cancer].
    Chen KZ; Yang F; Wang X; Jiang GC; Li JF; Wang J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Apr; 47(2):295-301. PubMed ID: 25882948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a clinical prediction model for N2 lymph node metastasis in non-small cell lung cancer.
    Chen K; Yang F; Jiang G; Li J; Wang J
    Ann Thorac Surg; 2013 Nov; 96(5):1761-8. PubMed ID: 23998401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prediction model for N2 disease in T1 non-small cell lung cancer.
    Zhang Y; Sun Y; Xiang J; Zhang Y; Hu H; Chen H
    J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1360-4. PubMed ID: 22819364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Model Predicting Lymph Node Status for Patients with Clinical Stage T1aN0-2M0 Nonsmall Cell Lung Cancer.
    Zang RC; Qiu B; Gao SG; He J
    Chin Med J (Engl); 2017 Feb; 130(4):398-403. PubMed ID: 28218211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Texture Analysis-Based Prediction Model for Lymph Node Metastasis in Stage IA Lung Adenocarcinoma.
    Gu Y; She Y; Xie D; Dai C; Ren Y; Fan Z; Zhu H; Sun X; Xie H; Jiang G; Chen C
    Ann Thorac Surg; 2018 Jul; 106(1):214-220. PubMed ID: 29550204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Prediction Model to Help with the Assessment of Adenopathy in Lung Cancer: HAL.
    O'Connell OJ; Almeida FA; Simoff MJ; Yarmus L; Lazarus R; Young B; Chen Y; Semaan R; Saettele TM; Cicenia J; Bedi H; Kliment C; Li L; Sethi S; Diaz-Mendoza J; Feller-Kopman D; Song J; Gildea T; Lee H; Grosu HB; Machuzak M; Rodriguez-Vial M; Eapen GA; Jimenez CA; Casal RF; Ost DE
    Am J Respir Crit Care Med; 2017 Jun; 195(12):1651-1660. PubMed ID: 28002683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Risk factor analysis of mediastinal lymph node metastasis in non-small cell lung cancer patients and the strategy of mediastinoscopy prior to surgery].
    Wang X; Zheng L; Zhang SY; Xie ZM; Yu H; Su XD; Wang JY; Huang ZF; Yang MT; Rong TH
    Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):456-9. PubMed ID: 19950559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Prediction Model to Help with Oncologic Mediastinal Evaluation for Radiation: HOMER.
    Martinez-Zayas G; Almeida FA; Simoff MJ; Yarmus L; Molina S; Young B; Feller-Kopman D; Sagar AS; Gildea T; Debiane LG; Grosu HB; Casal RF; Arain MH; Eapen GA; Jimenez CA; Noor LZ; Baghaie S; Song J; Li L; Ost DE
    Am J Respir Crit Care Med; 2020 Jan; 201(2):212-223. PubMed ID: 31574238
    [No Abstract]   [Full Text] [Related]  

  • 9. [Application of a Radiomics Model for Preding Lymph Node Metastasis in Non-small Cell Lung Cancer].
    Zhu J; Xu WG; Xiao H; Zhou Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 May; 50(3):373-378. PubMed ID: 31631606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive factors for node metastasis in patients with clinical stage I non-small cell lung cancer.
    Cho S; Song IH; Yang HC; Kim K; Jheon S
    Ann Thorac Surg; 2013 Jul; 96(1):239-45. PubMed ID: 23673071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative Risk Assessment of Lymph Node Metastasis in cT1 Lung Cancer: A Retrospective Study from Eastern China.
    Zhang C; Pang G; Ma C; Wu J; Wang P; Wang K
    J Immunol Res; 2019; 2019():6263249. PubMed ID: 31886306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prediction model for pathologic N2 disease in lung cancer patients with a negative mediastinum by positron emission tomography.
    Farjah F; Lou F; Sima C; Rusch VW; Rizk NP
    J Thorac Oncol; 2013 Sep; 8(9):1170-80. PubMed ID: 23945387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinical prediction rule to estimate the probability of mediastinal metastasis in patients with non-small cell lung cancer.
    Shafazand S; Gould MK
    J Thorac Oncol; 2006 Nov; 1(9):953-9. PubMed ID: 17409978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive risk factors for mediastinal lymph node metastasis in clinical stage IA non-small-cell lung cancer patients.
    Koike T; Koike T; Yamato Y; Yoshiya K; Toyabe S
    J Thorac Oncol; 2012 Aug; 7(8):1246-51. PubMed ID: 22659962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of primary fluorine-18 fluorodeoxyglucose standard uptake value for a better choice of systematic nodal dissection or sampling in clinical stage ia non--small-cell lung cancer.
    Li X; Zhang H; Xing L; Xu X; Xie P; Ma H; Zhang L; Chen M; Sun X; Xu W; Chen L; Yu J
    Clin Lung Cancer; 2013 Sep; 14(5):568-73. PubMed ID: 23835164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of maximum standardized uptake value with occult mediastinal lymph node metastases in cN0 non-small cell lung cancer.
    Lin JT; Yang XN; Zhong WZ; Liao RQ; Dong S; Nie Q; Weng SX; Fang XJ; Zheng JY; Wu YL
    Eur J Cardiothorac Surg; 2016 Nov; 50(5):914-919. PubMed ID: 27113090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prediction model for lymph node metastases using pathologic features in patients intraoperatively diagnosed as stage I non-small cell lung cancer.
    Zhao F; Zhou Y; Ge PF; Huang CJ; Yu Y; Li J; Sun YG; Meng YC; Xu JX; Jiang T; Zhang ZX; Sun JP; Wang W
    BMC Cancer; 2017 Apr; 17(1):267. PubMed ID: 28407802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of surgical intervention for p-stage IIIA (N2) non-small cell lung cancer: acceptable prognosis predicted by complete resection in patients with single N2 disease with primary tumor in the upper lobe.
    Inoue M; Sawabata N; Takeda S; Ohta M; Ohno Y; Maeda H
    J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1100-6. PubMed ID: 15052208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcarinal Lymph Nodes Should be Dissected in All Lobectomies for Non-Small Cell Lung Cancer-Regardless of Primary Tumor Location.
    Eckardt J; Jakobsen E; Licht PB
    Ann Thorac Surg; 2017 Apr; 103(4):1121-1125. PubMed ID: 28109572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinicopathological features associated with skip N2 metastases in patients with clinical stage IA non-small-cell lung cancer.
    Gorai A; Sakao Y; Kuroda H; Uehara H; Mun M; Ishikawa Y; Nakagawa K; Masuda M; Okumura S
    Eur J Cardiothorac Surg; 2015 Apr; 47(4):653-8. PubMed ID: 24957260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.